(HealthDay News) — There are no significant clinical differences between the use of a breath-actuated nebulizer (BAN) and a handheld nebulizer (HHN) for the treatment of wheezing or dyspnea among ...
BUFORD, Ga. , Jan. 25, 2023 (GLOBE NEWSWIRE) -- Synergy Life Science, Inc. (“Synergy”), a company pioneering the development of novel ingredients and innovative products for the consumer health and ...
DURHAM, N.C.--(BUSINESS WIRE)--Inhalon Biopharma (Inhalon), a clinical-stage company advancing a proprietary inhaled antibody platform for treating acute respiratory infections (ARI), today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback